These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36816621)

  • 1. Outcomes of COVID-19 among patients with liver disease.
    Vujčić I
    World J Gastroenterol; 2023 Feb; 29(5):815-824. PubMed ID: 36816621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-adjusted mortality and predictive value of liver chemistries in a Viennese cohort of COVID-19 patients.
    Hartl L; Haslinger K; Angerer M; Jachs M; Simbrunner B; Bauer DJM; Semmler G; Scheiner B; Eigenbauer E; Strassl R; Breuer M; Kimberger O; Laxar D; Trauner M; Mandorfer M; Reiberger T
    Liver Int; 2022 Jun; 42(6):1297-1307. PubMed ID: 35412018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High rates of 30-day mortality in patients with cirrhosis and COVID-19.
    Iavarone M; D'Ambrosio R; Soria A; Triolo M; Pugliese N; Del Poggio P; Perricone G; Massironi S; Spinetti A; Buscarini E; Viganò M; Carriero C; Fagiuoli S; Aghemo A; Belli LS; Lucà M; Pedaci M; Rimondi A; Rumi MG; Invernizzi P; Bonfanti P; Lampertico P
    J Hepatol; 2020 Nov; 73(5):1063-1071. PubMed ID: 32526252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis.
    Kumar-M P; Mishra S; Jha DK; Shukla J; Choudhury A; Mohindra R; Mandavdhare HS; Dutta U; Sharma V
    Hepatol Int; 2020 Sep; 14(5):711-722. PubMed ID: 32623633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver dysfunction and SARS-CoV-2 infection.
    Gracia-Ramos AE; Jaquez-Quintana JO; Contreras-Omaña R; Auron M
    World J Gastroenterol; 2021 Jul; 27(26):3951-3970. PubMed ID: 34326607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis.
    Del Zompo F; De Siena M; Ianiro G; Gasbarrini A; Pompili M; Ponziani FR
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13072-13088. PubMed ID: 33378061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study).
    Sarin SK; Choudhury A; Lau GK; Zheng MH; Ji D; Abd-Elsalam S; Hwang J; Qi X; Cua IH; Suh JI; Park JG; Putcharoen O; Kaewdech A; Piratvisuth T; Treeprasertsuk S; Park S; Wejnaruemarn S; Payawal DA; Baatarkhuu O; Ahn SH; Yeo CD; Alonzo UR; Chinbayar T; Loho IM; Yokosuka O; Jafri W; Tan S; Soo LI; Tanwandee T; Gani R; Anand L; Esmail ES; Khalaf M; Alam S; Lin CY; Chuang WL; Soin AS; Garg HK; Kalista K; Batsukh B; Purnomo HD; Dara VP; Rathi P; Al Mahtab M; Shukla A; Sharma MK; Omata M;
    Hepatol Int; 2020 Sep; 14(5):690-700. PubMed ID: 32623632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020.
    Mallet V; Beeker N; Bouam S; Sogni P; Pol S;
    J Hepatol; 2021 Oct; 75(4):848-855. PubMed ID: 33992699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of COVID-19 on the liver: The experience of a single center.
    Liakina V; Stundiene I; Milaknyte G; Bytautiene R; Reivytyte R; Puronaite R; Urbanoviciute G; Kazenaite E
    World J Gastroenterol; 2022 Oct; 28(39):5735-5749. PubMed ID: 36338891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination.
    Nevola R; Criscuolo L; Beccia D; Delle Femine A; Ruocco R; Imbriani S; Alfano M; Villani A; Russo A; Perillo P; Marfella R; Adinolfi LE; Sasso FC; Marrone A; Rinaldi L
    World J Gastroenterol; 2023 Feb; 29(5):800-814. PubMed ID: 36816617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE2: from protection of liver disease to propagation of COVID-19.
    Warner FJ; Rajapaksha H; Shackel N; Herath CB
    Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 infection in patients with a normal or abnormal liver.
    Cabibbo G; Rizzo GEM; Stornello C; Craxì A
    J Viral Hepat; 2021 Jan; 28(1):4-11. PubMed ID: 33190321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study.
    Afify S; Eysa B; Hamid FA; Abo-Elazm OM; Edris MA; Maher R; Abdelhalim A; Abdel Ghaffar MM; Omran DA; Shousha HI
    World J Gastroenterol; 2021 Nov; 27(42):7362-7375. PubMed ID: 34876795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2-positive patients.
    Ponziani FR; Del Zompo F; Nesci A; Santopaolo F; Ianiro G; Pompili M; Gasbarrini A;
    Aliment Pharmacol Ther; 2020 Sep; 52(6):1060-1068. PubMed ID: 32628793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of liver injury in risk-stratification and management of patients with COVID-19.
    Shao J; Liang Y; Li Y; Ding R; Zhu M; You W; Wang Z; Huang B; Wu M; Zhang T; Li K; Wu W; Wu L; Wang Q; Xia X; Wang S; Lu L
    Hepatol Int; 2021 Feb; 15(1):202-212. PubMed ID: 33548030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of New-Onset Liver Injuries Due to COVID-19 in Preexisting Hepatic Conditions-Review of the Literature.
    Bucurica S; Ionita Radu F; Bucurica A; Socol C; Prodan I; Tudor I; Sirbu CA; Plesa FC; Jinga M
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver and Biliary Tract Disease in Patients with Coronavirus disease-2019 Infection.
    Ekpanyapong S; Reddy KR
    Gastroenterol Clin North Am; 2023 Mar; 52(1):13-36. PubMed ID: 36813421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiological mechanisms of liver injury in COVID-19.
    Nardo AD; Schneeweiss-Gleixner M; Bakail M; Dixon ED; Lax SF; Trauner M
    Liver Int; 2021 Jan; 41(1):20-32. PubMed ID: 33190346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 and liver disease.
    Dufour JF; Marjot T; Becchetti C; Tilg H
    Gut; 2022 Nov; 71(11):2350-2362. PubMed ID: 35701093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.